BACKGROUND: Membranous nephropathy (MN) and kidney renal clear cell carcinoma (KIRC) are distinct kidney diseases with potential shared molecular mechanisms. Identifying common biomarkers may improve our understanding of disease pathogenesis and provide novel diagnostic and therapeutic targets. METHODS: The study primarily employed bioinformatics tools to analyze publicly available datasets to identify differentially expressed genes (DEGs) and hub genes in KIRC and MN. Functional interactions of the common DEGs were explored using protein-protein interaction (PPI) networks, and hub genes were further investigated through gene expression databases such as GSCA and UALCAN. Gene Set Enrichment Analysis (GSEA) was used to assess functional enrichment and tumor-driving potential. These bioinformatic results were then experimentally validated by knocking down FYN and LGALS8 in 786-O cells using siRNA, followed by RT-qPCR, protein analysis, and functional assays. RESULTS: The study identified four hub genes (FYN, LGALS8, MAGI2, and WT1) in KIRC and MN, with FYN and LGALS8 upregulated and MAGI2 and WT1 downregulated. Bioinformatics validation showed excellent diagnostic performance and confirmed methylation and mutation patterns. Higher FYN and LGALS8 expression were linked to poorer survival. miRNA downregulation was validated in KIRC cell lines. Functional analysis revealed that FYN and LGALS8 promote KIRC progression through the ErbB signaling pathway, and knockdown experiments reduced cell proliferation, migration, and colony formation. CONCLUSION: Our findings identify FYN, LGALS8, MAGI2, and WT1 as hub genes in KIRC, with potential diagnostic and prognostic value. These genes play significant roles in methylation, mutation, and immune regulation in KIRC. However, the results from the limited MN samples suggest possible roles of these genes in MN pathology, but further studies are required to fully assess the relevance of these findings to MN.
Shared hub genes in membranous nephropathy and kidney renal clear cell carcinoma: investigating molecular overlap and tumor progression.
膜性肾病和肾透明细胞癌的共同枢纽基因:研究分子重叠和肿瘤进展
阅读:6
作者:Hui Peng, Shuwen Zhang
| 期刊: | Discover Oncology | 影响因子: | 2.900 |
| 时间: | 2025 | 起止号: | 2025 Jun 9; 16(1):1035 |
| doi: | 10.1007/s12672-025-02701-1 | 研究方向: | 细胞生物学、肿瘤 |
特别声明
1、本文转载旨在传播信息,不代表本网站观点,亦不对其内容的真实性承担责任。
2、其他媒体、网站或个人若从本网站转载使用,必须保留本网站注明的“来源”,并自行承担包括版权在内的相关法律责任。
3、如作者不希望本文被转载,或需洽谈转载稿费等事宜,请及时与本网站联系。
4、此外,如需投稿,也可通过邮箱info@biocloudy.com与我们取得联系。
